| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.20B | 750.50M | 3.28B | 2.23B | -414.30M | 3.03B |
| Gross Profit | 750.50M | 750.50M | 635.90M | 652.20M | 1.36B | 1.79B |
| EBITDA | 1.07B | 1.11B | 924.70M | 970.50M | 414.30M | 1.17B |
| Net Income | 192.30M | 192.30M | 129.90M | 287.50M | 253.70M | 592.30M |
Balance Sheet | ||||||
| Total Assets | 34.95B | 34.95B | 33.41B | 30.98B | 29.74B | 29.99B |
| Cash, Cash Equivalents and Short-Term Investments | 32.39B | 32.39B | 573.20M | 593.40M | 733.10M | 989.40M |
| Total Debt | 8.27B | 8.27B | 7.13B | 5.89B | 5.85B | 6.39B |
| Total Liabilities | 31.09B | 31.09B | 29.52B | 26.81B | 25.75B | 26.17B |
| Stockholders Equity | 3.86B | 3.86B | 3.88B | 4.16B | 3.99B | 3.83B |
Cash Flow | ||||||
| Free Cash Flow | 399.40M | 399.40M | 841.80M | 1.27B | 2.48B | 2.56B |
| Operating Cash Flow | 399.60M | 399.60M | 843.70M | 1.27B | 2.49B | 2.58B |
| Investing Cash Flow | -1.18B | -1.18B | -1.94B | -1.34B | -2.12B | -865.00M |
| Financing Cash Flow | 854.70M | 854.70M | 1.08B | -35.00M | -619.80M | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | AU$130.12M | 16.63 | 8.88% | ― | 21.79% | -23.00% | |
64 Neutral | AU$7.56B | 64.73 | 67.81% | 1.43% | 28.29% | 39.39% | |
61 Neutral | AU$3.67B | 26.97 | 19.56% | 3.77% | 37.42% | 38.37% | |
60 Neutral | AU$6.14B | 31.86 | 4.84% | 3.32% | 11.78% | 47.53% | |
56 Neutral | AU$1.66B | 19.57 | 5.31% | ― | 16.78% | 22.86% | |
50 Neutral | €2.16B | -36.55 | -3.34% | 6.35% | 2.87% | 87.93% |
Challenger Limited reported a strong start to FY26 with a 4% increase in total life sales, driven by significant growth in annuity sales. The company is making strategic progress by forming partnerships with superannuation funds and launching new products, such as the ASX listed income notes, LiFTS, to meet the demand for guaranteed retirement income. Despite a decrease in funds under management, Challenger is expanding its offerings and remains well-capitalized, positioning itself for future growth amid upcoming regulatory changes that are expected to benefit the industry and retirees.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the issuance of 1,548,539 performance rights as part of an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, indicating a move to reward and retain key personnel, potentially impacting the company’s operational dynamics and aligning employee interests with corporate goals.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the cessation of 298,281 performance rights due to the lapse of conditional rights that were not satisfied. This development may affect the company’s capital structure and could have implications for stakeholders regarding the company’s future performance and strategic direction.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced changes in its shareholding structure, specifically regarding its interests and derivative exposures. The company, through its controlled entities, has a minor interest in 33,429 ordinary shares, representing 0.0048% of total shares. Recent changes include acquisitions and forfeitures of shares by the Challenger Performance Plan Trust, affecting the company’s overall shareholding and potentially its market positioning.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that it has ceased to be a substantial holder in The A2 Milk Company Limited. This change in holdings reflects a strategic decision by Challenger, potentially impacting its investment portfolio and signaling a shift in its market focus. The announcement may have implications for stakeholders as it indicates a reallocation of resources or a change in investment strategy.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that it has ceased to be a substantial holder in IRESS Limited, indicating a change in its investment position. This move may impact Challenger’s portfolio strategy and reflects a shift in its investment focus, potentially affecting stakeholders and market perceptions.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced the issue price for its final 2025 Dividend Reinvestment Plan (DRP) at $8.3615 per share, with a participation rate of 2% of issued capital. This move will see 265,790 new ordinary shares issued to DRP participants, potentially impacting the company’s market positioning by increasing shareholder engagement and capital retention.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the issuance of 265,790 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code CGF. This move is part of a dividend or distribution plan, potentially impacting the company’s market presence by increasing its available securities and providing more investment opportunities for stakeholders.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has updated its previous announcement regarding the dividend distribution for its ordinary fully paid securities. The update pertains to the Dividend Reinvestment Plan (DRP) price, which is relevant for the six-month financial period ending on June 30, 2025. This announcement impacts shareholders who participate in the DRP, as it affects the terms under which dividends are reinvested, potentially influencing the company’s market positioning and shareholder relations.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced a change in the director’s interest, with Nicolas Hamilton acquiring an additional 89,819 Restricted Shares under the Challenger Performance Plan. This acquisition increases his total holdings to 1,375,477 Performance Rights and Restricted Shares, reflecting the company’s ongoing commitment to aligning management interests with shareholder value.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced a change in the director’s interest, with Nicolas Hamilton increasing his holdings in the company. This change reflects the vesting of restricted shares and performance share rights under the Challenger Performance Plan, indicating a strategic alignment with the company’s long-term performance goals.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced a new dividend distribution for its security CGFPD, with a distribution amount of AUD 1.26. The payment is scheduled for November 25, 2025, with an ex-date of November 14, 2025, and a record date of November 17, 2025. This discretionary distribution is subject to no existing payment conditions on the payment date, reflecting Challenger’s ongoing commitment to providing returns to its stakeholders.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.20 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a new distribution for its Capital Notes 3, with a payment of AUD 1.44 per note scheduled for November 25, 2025. This discretionary distribution is contingent on the absence of any payment conditions and reflects Challenger’s ongoing commitment to providing returns to its investors, potentially impacting its market positioning and investor relations positively.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.20 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that it has ceased to be a substantial holder in The A2 Milk Company Limited. This change in holding status indicates a shift in Challenger’s investment strategy, which could impact its portfolio and influence its market positioning. Stakeholders may view this move as a strategic reallocation of resources, potentially affecting their interests and the company’s future investment directions.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.20 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a revision to its 2025 financial calendar, postponing the 2025 Investor Day originally scheduled for September 16, 2025, due to investor feedback. The company is currently in discussions with APRA regarding changes to capital settings for annuity products and will announce a new date for the Investor Day following these consultations. Other dates in the financial calendar remain unchanged, and any further changes will be communicated to the ASX.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.20 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of August 21, 2025. This change in substantial holding could impact the company’s shareholder structure and influence in the market, potentially affecting its strategic decisions and stakeholder interests.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.20 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced the resignation of Mr. Masahiko Kobayashi from its Board following the sale of MS&AD’s equity holding in Challenger to TAL Dai-ichi Life Australia. Mr. Kobayashi, who has served as a Non-Executive Director since 2019, played a key role in fostering a strong relationship between Challenger and MS&AD, contributing significantly to the company’s strategic direction. His departure marks a significant change in the board’s composition, but the existing partnership with Mitsui Sumitomo Primary Life Insurance Company Limited remains strong, as evidenced by the successful renewal of their reinsurance partnership.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.35 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited, a prominent player in Australia’s retirement income sector, specializes in providing annuities and managing funds to ensure financial security for retirees. The company has marked a significant milestone with its 40th anniversary, showcasing robust financial performance and strategic advancements in the digital realm. Key highlights from the recent earnings report include a 9% increase in normalised net profit after tax to $456 million, a rise in return on equity to 11.8%, and an 11% hike in full-year dividends. Challenger’s strategic focus on expanding its retirement income solutions and digital transformation initiatives has positioned it well for future growth. The company remains committed to maintaining strong shareholder outcomes and capital management, with a forward-looking approach to enhancing its market leadership and meeting the evolving needs of retirees.
Challenger Limited has announced a dividend distribution for its ordinary fully paid securities, with a distribution amount of AUD 0.15 per share. The dividend relates to the six-month period ending June 30, 2025, and will be paid on September 18, 2025, impacting stakeholders by providing a return on investment and potentially influencing the company’s market positioning.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger has released its 2025 Corporate Governance Statement, outlining its adherence to eight key principles aimed at enhancing management oversight, board effectiveness, ethical conduct, and risk management. The statement, part of their comprehensive annual reporting suite, reflects Challenger’s commitment to transparency and stakeholder engagement, providing insights into their governance and performance from July 2024 to June 2025.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has released its corporate governance statement for the financial year ending June 30, 2025. The statement, which is available on their website, outlines the extent to which the company has adhered to the recommendations set by the ASX Corporate Governance Council. This disclosure is crucial for stakeholders as it provides transparency regarding the company’s governance practices and compliance with ASX listing rules.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger has reported a strong financial performance for the 2025 fiscal year, with a 9% increase in normalised net profit after tax to $456 million and a 48% rise in statutory net profit after tax to $192 million. The company has successfully executed strategic initiatives, including a digital transformation and expansion of its asset origination platform, which positions it well for future growth. With a focus on the growing retirement income market, Challenger has achieved record sales in retail lifetime and Japanese annuities, reflecting rising demand for guaranteed lifetime income. The company remains strongly capitalised, with significant excess capital to support ongoing growth, and has made substantial progress in its partnerships and customer solutions.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has released its FY25 financial highlights, showcasing significant strategic progress and key performance indicators. The company has maintained a strong balance sheet, with a focus on enhancing its market position through partnerships and regulatory compliance. This announcement reflects Challenger’s commitment to delivering stable financial results and adapting to regulatory changes, which could have implications for stakeholders and its competitive standing in the financial services sector.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced strong financial results for FY25, with a 9% increase in normalised net profit after tax to $456 million, aligning with its earnings guidance. The company reported record sales in retail lifetime and Japanese annuities, highlighting its successful growth strategy and digital transformation efforts. Challenger’s strategic initiatives, including new retirement partnerships and the launch of an innovative income platform, position it well to meet the increasing demand for retirement income solutions. The company also declared a fully franked dividend of 29.5 cents per share, marking an 11% increase from the previous year.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited’s 2025 Annual Review highlights a significant year marked by strong financial performance and strategic advancements in the retirement income market in Australia. The company is undergoing a digital transformation to enhance its growth opportunities and aims to further support Australians in their retirement years, reflecting a positive outlook for stakeholders.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited is celebrating its 40th anniversary with a strong financial performance and significant progress in the retirement income market. The company is embarking on a digital transformation to enhance its growth strategy, aiming to help more Australians enjoy their retirement. The upcoming Annual General Meeting will be held as a hybrid event, allowing both physical and virtual attendance, reflecting Challenger’s commitment to accessibility and innovation.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited reported a significant increase in its statutory net profit after tax, rising by 48% to $192.3 million for the year ending June 30, 2025, driven by improved underlying performance and reduced asset and liability experience losses. The company’s normalised net profit after tax also saw a 9.3% increase, reaching $455.5 million, attributed to higher net income and reduced interest and borrowing costs. The board announced a continuation of the Dividend Reinvestment Plan, with total dividends per share increasing by 11.3% to 29.5 cents, reflecting the company’s strong financial performance.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that MS&AD Insurance Group Holdings, Inc has ceased to be a substantial holder in the company. This change in shareholding could impact Challenger Limited’s market dynamics and investor relations, as substantial holders often influence company strategies and market perceptions.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
TAL Dai-ichi Life Australia Pty Limited has completed its acquisition of a 19.9% equity interest in Challenger Limited, following the receipt of all necessary regulatory approvals. This investment is expected to impact Challenger’s operations by potentially enhancing its market positioning and providing strategic benefits to its stakeholders.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.